Envisioning the Infrastructure to Support Drone Deliveries

Both pilots and companies are navigating a thin line between security and innovation. Host Grant Guillot talks with leaders, influencers, and experts across the drone industry to guide us through the complex web of technology and policy in the United States.

 

This could be the golden age of drone delivery. However, like any form of logistics, it requires a fully developed infrastructure. Many players in the industry are working to make this happen. Drones in America host Grant Guillot spoke with two stakeholders in this initiative, Sid Venkat, Global Account Manager, and Tobias Hoffman, Head of Research and Development, of EVA.

Venkat described the company’s story, “We noticed a huge gap in making the infrastructure for drone operations to reach its full potential.”

“Infrastructure is building the future roads for drones.” -Tobias Hoffman

That’s where the company turned, and now has a global reach, working with a variety of interested parties. Venkat explained, “There’s a mix of government and private business contributing. It depends on the country. Malaysia is a champion in their region, building robotic cities and creating ecosystems.”

EVA’s focus is on drone stations and fleet management as the footing of the infrastructure. “When drone operations reach a certain threshold, there are safety and efficiency factors. Drone stations centralize and allow for takeoff, landing, and gathering intelligence,” Venkat said.

Hoffman offered this parallel to describe the importance of infrastructure, “It’s like building the future roads for drones, and the drone stations are like gas stations. It collects data, which anyone can use, and can determine if drone corridors are safe.”

To achieve full-scale drone delivery, operators need the same type of structure as any other mode of transportation. EVA and its partners are focusing on all types of drones at different sizes and payloads. Hoffman added, “It’s a last mile solution and more, so it’s certainly the foundation for drone infrastructure.”

See Previous Episodes of Drones In America Here

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More